TABLE 1.
No. of patients | No. of patients (%) | |
---|---|---|
Tumor site | ||
Oral cavity | 429 | 28% |
Oropharynx a | 624 | 41% |
Hypopharynx | 170 | 11% |
Larynx | 314 | 20% |
Clinical stage (TNM7) | ||
III | 393 | 26% |
IVA | 1001 | 65% |
IVB | 143 | 9% |
Gender | ||
Male | 1097 | 71% |
Female | 440 | 29% |
Age at diagnosis | Median 62 years (range 20‐93) | |
Median follow‐up | 50.5 months (95% CI 47.9‐54.2) |
377 were p16 positive (60%) and 247 (40%) were p16 negative.